BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 24, 2019
View Archived Issues
PDC-CA4A-109 shows antitumor activity in breast and colon cancer models
Read More
MYCN-targeting antigene peptide oligonucleotide inhibits growth of MYCN-amplified neuroblastoma
Read More
Extension study results evaluating safety and effectiveness of dasotraline in binge-eating disorders
Read More
Maternal Zika vaccination protects macaque pregnancies
Read More
Jazz Pharmaceuticals enrolling patients in phase II/III study of JZP-458 for ALL/LBL
Read More
Gilead evaluates GS-6207 with other antiretrovirals for HIV in new phase II study
Read More
IL-1beta as a promising new biomarker in treatment-resistant bipolar depression
Read More
Interim data from gene therapy trial confirm BCL11A as therapeutic target in SCD
Read More
Lumateperone approved in the U.S. for schizophrenia
Read More
Trial to evaluate Trevena's TRV-734 for opioid use disorder
Read More
Phase II study begins for URO-902 in overactive bladder
Read More
PET imaging agent PyL meets primary endpoint in phase III prostate cancer trial
Read More
Phase I study of mutant EGFR inhibitor TQB-3804 begins
Read More
Celgene presents results from two phase I studies of CC-90002
Read More
CAPELLA trial recruits patients with HIV to evaluate add-on lenacapavir treatment
Read More
FDA approves first trial of ST-001 nanoFenretinide in T-cell non-Hodgkin's lymphoma
Read More
ABL Bio describes new anti-B7-H3 antibodies
Read More
Ubrogepant approved by the FDA for migraine
Read More
Lankenau Institute for Medical Research patents anti-rabies antibodies
Read More
New anti-OX40 antibodies synthesized at BeiGene
Read More
Apros Therapeutics discovers TLR7 peptide conjugates
Read More
Metastatic melanoma is targetable with lactate transport inhibitors
Read More
